Autolus Therapeutics plc
Customers
1
0 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Dec 31, 2024
10-K filed 2025-03-20
Customers 1
Companies AUTL discloses as major customers, as a share of AUTL revenue. 0 active, 1 lapsed.
| Company | % of AUTL revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| BNTX BioNTech SE |
100% | $10.1M | FY 2024-12-31 | ±0.0pp | Lapsed Last seen 2024-12-31 |
10-K 2025-03-20 |
During the year ended December 31, 2024, 100% of the Company’s license revenues were generated from BioNTech. During the three and six months ended June 30, 2024, 100% of the Company’s license revenues were generated from BioNTech. During the three months ended March 31, 2024, 100% of the Company’s license revenues were generated from BioNTech. | ||||||
Alerts are coming
Get an email when AUTL's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.